Leire Escudero-Ibarz

She leads cross-functional teams in functional genomics and target validation across oncology, immunology, and cell therapy. With a PhD in Cancer Genetics from the University of Cambridge and experience at GSK and Horizon Discovery, she specializes in scalable CRISPR-based screening and iPSC capabilities. An entrepreneurial leader and co-founder, she bridges cutting-edge science with patient impact. Beyond R&D, she builds scientific communities as a founding leader for HBA Cambridge and a mentor for innovation programs.